Status:
NOT_YET_RECRUITING
Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD
Lead Sponsor:
Assiut University
Conditions:
Essential Phospholipid in Metabolic Associated Fatty Liver Disease
Eligibility:
All Genders
18-60 years
Brief Summary
To evaluate the efficacy of Essential phospholipid versus Betaine HCL/L-Glutamic Acid in MAFLD
Detailed Description
The prevalence of non-alcoholic fatty liver disease (NAFLD) increases rapidly in recent decades. NAFLD has become a major public health problem in the whole world, and it is considered as the main cau...
Eligibility Criteria
Inclusion
- All patients aged \>18 years old
- diagnosed as fatty liver based on clinical examination, laboratory investigations and imaging techniques.
Exclusion
- Patients aged ≤18 years old.
- Pregnancy.
- Presence of malignancy.
- Type I DM.
- Fatty liver patients on treatment by statin derivatives or other medications.
- Fatty liver patients undergone bariatric surgeries
Key Trial Info
Start Date :
November 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT07194863
Start Date
November 1 2025
End Date
September 1 2027
Last Update
October 2 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.